This Article Full Text Full Text (PDF) All Versions of this Article: 29/5/506    most recent Author Manuscript (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Radpour, R. Articles by Zhong, X. Y. PubMed PubMed Citation Articles by Radpour, R. Articles by Zhong, X. Y.

Review

Genetic Investigations of CFTR Mutations in Congenital Absence of Vas Deferens, Uterus, and Vagina as a Cause of Infertility

RAMIN RADPOUR^*,

HAMID GOURABI

AHMAD VOSOUGH DIZAJ

From the ^* Laboratory for Prenatal Medicine and Gynecologic Oncology, Women's Hospital/Department of Medicine, University of Basel, Switzerland; and the Department of Reproductive Genetics, Reproductive Biomedicine Research Center of Royan Institute, Tehran, Iran.

Correspondence to: Dr Ramin Radpour, Laboratory for Prenatal Medicine and Gynecologic Oncolocy, Women's Hospital/Department of Medicine, University of Basel, Switzerland (e-mail: radpourr{at}uhbs.ch).

Abstract

A qualitative diagnosis of infertility requires attention to male and female physical abnormalities including endocrine anomalies and genetic conditions that interfere with reproduction. Many genes are likely to be involved in the complex process of reproduction. Congenital bilateral absence of the vas deferens (CBAVD) is a genital form of cystic fibrosis (CF) that is responsible for 2%–6% of male infertility. The incidence of CF varies in different populations; therefore, the incidence of CBAVD will also vary in different populations. The spectrum and distribution of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations differ between CBAVD and CF patients and are comparable to control individuals. Combinations of particular alleles at several polymorphic loci yield insufficient functional CFTR protein. CFTR mutations are also associated with congenital absence of the uterus and vagina (CAUV). Females with CF are found to be less fertile than normal healthy women. Because of techniques such as intracytoplasmic sperm injection (ICSI), CBAVD patients are now able to father children. Such couples, however, have an increased risk of having a child with cystic fibrosis, and therefore genetic testing and counseling should be provided. Around 10% of obstructive azoospermia is congenital and due to mutations in the CF gene. This review highlights the relationship of mutations in the CFTR gene with CBAVD and CAUV.